Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Instil Bio Inc TIL

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.


NDAQ:TIL - Post by User

Bullboard Posts
Post by Guavaon Sep 29, 2011 7:50am
481 Views
Post# 19097169

How many more years of Yukon exploration?

How many more years of Yukon exploration?Can Yukon exploration survive one more year? In three years of exploration, there are only three projects with resources (White Gold/Underworld (K.TO), Prophecy (NKL.V), and Dublin Gulch (VIT.V)). GPD is a company with three 43-101 resource estimation reports ahead. We hope that the results are coming very positive. Expecting also resource estimation from ATAC and KAM at the end of the year. We hope getting from these 5 projects at least 10-15Moz of gold.. If not, I can not see any interest from a major company in this area in the near future. 
There are more than 60 junior companies exploring in the Yukon territory, however most of them are speculating with soil sample ppb results, and raising million and million of dollars (What the heck is that!).. Good examples are PEX, CEM, TAK, AML, CBC, RYG, and so on.. Those stocks are in red, and will keep in red because the field exploration already finishes.
Last thought, GPD does not speculate with soil sample numbers.. they give us drill-hole intercepts and still drilling in some properties.
Bullboard Posts